Degirmenci, U., Wang, M., & Hu, J. (2020, January). Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy. Cells.
Chicago Style (17th ed.) CitationDegirmenci, Ufuk, Mei Wang, and Jiancheng Hu. "Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy." Cells Jan. 2020.
MLA (9th ed.) CitationDegirmenci, Ufuk, et al. "Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy." Cells, Jan. 2020.
Warning: These citations may not always be 100% accurate.
